This template doesn't support hiding the navigation bar.
  • broken image

    Dedicated to improving human health by facilitating key medical breakthroughs and their applications worldwide

  • ABOUT

    Ming Capital is a global healthcare venture capital firm

    founded in Shenzhen, China in April 2015.

    Strategy

    • Support global medical breakthroughs (especially in innovative medicine, medical device, IVD).
    • Facilitate worldwide resources combination of medical innovations, entrepreneurship, management, commercial markets, and capital markets through onshore-offshore parallel funds and parallel investments.

    Strategic Goals

       Support entrepreneurs.　 Prosper investors.　Reward partners.　 Enhance health.


    Values

    Collective wisdom and intelligence of integrity for value creation.

     

  • MANAGEMENT TEAM

    An international and professional team with veteran management

    broken image

    Jack (Bing) Yang

    Founding Partner

    • Over 25 year experiences in (VC/PE) investment and M&A investment banking acquired with New Hope Industry Funds, Rothschild Investment Banking, China Leasing, etc. in Beijing, Tokyo, London, Hong Kong, and Shenzhen
    • BA Economics, Peking University; MS Finance, London Business School
    broken image

    Lisa (Li) Feng

    Partner

    • Over 20 year experiences in pharmaceutical industry with Brightech International, Theravance, Anacor Pharmaceuticals, Kosan Biosciences
    • BS Chemistry, Peking University; MS Biochemistry and Molecular Biology, University of Iowa
    broken image

    Samuel (SY) Cheung

    Partner

    • Over 30 year experiences as an serial entrepreneur and senior management / board member with HK and PRC public and private companies

    broken image

    Xin Wan

    Partner

    • Over 30 year experiences as an serial entrepreneur in hi-tech, retail chains, bulk commodity, new energy, animation studios, creative parks, real estate, etc. and as an venture capitalist
    • BS Materials and MS Systems Engineering, Shanghai Jiao Tong University
    broken image

    Howard (QH) Fu

    Managing Director

    • Over 15 year experiences in healthcare and life science industries with functions ranging from neuroscience research, marketing research and investment
    • BS Biology, Peking University; MS Neuroscience, Boston University; MBA, Washington University in St. Louis
    broken image

    Ofer Hornick (MD)

    Senior Consultant Regulatory Affairs

    • Over 20 year experiences in R&D, regulatory affairs (FDA, CE, etc.) and founding startups in the fields of medical devices and digital health
    • MD,  Sackler Faculty of Medicine, Tel-Aviv University

  • PORTFOLIO

    Support innovative companies in developing and utilizing world leading technologies to improve human life

    BeBetter Medicine is engaged in discovery and development of small molecule drugs for treating lymphoma, lung cancer , ovarian cancer, etc. Among its pipeline, BEBT-908 is a Class 1.1 dual target new drug against recurrent or refractory lymphoma. The company is based in Guanghzou, China.

    Binghui Biopharma is a leading developer of oncolytic virus immunotherapy in China with strong managment & team and proved commercial capabilities. The company is based next to Wuhan, China.

    Caretaker Medical® is a MedTech Innovator founded in Charlottesville, Virginia, in March 2014 to commercialize wearable monitoring devices constructed around our Patented Pulse Decomposition Analysis technology.

    EDADOC Technology is listed on the Shenzhen Growth Enterprise Market (Stock Code 301366). As a one-stop hardware innovation platform for PCB design, The company focuses on high-speed PCB layout designing & prototyping and large batch PCBA production. EDADOC Technology is based in Shenzhen, China.

    Eureka Biotech has developed world-class packaging and producer cell lines for generating genetically restructured lenti-virus at much lower production cost, and is also very strong in developing automated equipment for biotech R&D. The company has made solid progress in developing the equivalent cell lines for AAV. Eureka Biotech is based in Shenzhen, China.

    GeneVector Therapeutics has full intellectual property of and industry leading expertise in genetically engineering and production of AAV, and is focused on developing novel AAV based gene therapies for treating AMD, XLRS, etc. GeneVector Therapeutics is based in Chengdu, China.

    Gordian Surgical has developed TroClose, a port access-closure system that offers surgeons a simple, secure, and safe solution to open and close the abdominal wall during laparoscopic (minimally invasive) procedures. The company is based in Misgav, Israel.

    Human Xtensions is a medical robotics company developing software-driven handheld surgical devices that combine the advantages of robotics with the benefits of affordable handheld laparoscopic instruments. The company is based in Netanya, Israel.

    Miracor Medical is focused on clinically effective technology that will significantly improve the lives of patients suffering from cardiac disease. The Company is based in Awans, Belgium.

    SVision Imaging was founded by a group of scientists and industry veterans of Silicon Valley in 2014 with a core mission to develop the most advanced ophthalmic technologies. In 2015, the company’s base of operations moved to mainland China, and there are now three sites in Silicon Valley, Shanghai, and Luoyang.

  • EXITS

    Ming Capital spares no efforts in helping the investees and entrepreneurs succeed.

    Cucop

    Cucup uses its proprietary and leading DPI (deep packet inspection) technology to help owners of local internet networks in China to monitor and manage all network access points and generate revenue through big-data based business models such as precision advertising, etc.

    Keystone Heart

    Keystone Heart Ltd. is a medical device company developing and manufacturing cerebral embolic protection (CEP) device to reduce the risk of stroke.

    Supoin

    Supoin is a technology company providing automatic identification products, IoT mobile products and enterprise mobile application services.

  • NEWS

    broken image

    视微影像完成超3亿元C轮融资，眼科器械国产替代拐点已至

    动脉网独家获悉，视微影像有限公司（后文简称“视微”）目前宣布完成超3亿元人民币C轮融资。本轮融资由国寿股权与前海方舟领投，辰德资本、深创投、中金汇融、华创毅达、临港蓝湾、小明投资跟投，原机构股东继续加注，硬科技领域知名FA机构云岫资本担任独家财务顾问。

    broken image

    Yangtze River Pharmaceutical strategic investment in Binhui bio

    September 29th，2021

    Yangzi River Pharmaceutical Group reached a strategic cooperation with Wuhan Binhui Biotechnology Co., Ltd., an independent R & D enterprise of oncolytic virus drugs, and announced that the two sides would strengthen cooperation in the field of biomedicine.

    broken image

    Caretaker Medical receives new investment from Philips and others to enhance the Caretaker wireless Vital Signs patient monitoring platform

    Caretaker Medical, a leader in clinical-grade wireless patient monitoring and maker of the Caretaker® wearable patient monitor that utilizes a simple Finger Cuff to remotely measure “Beat by Beat” Continuous Blood Pressure and multiple vital signs has announced the completion of a Series B funding round from new investors Philips and Ming Capital, with participation from existing investors including IrishAngels, Felton Group LLC, and others.

  • CONTACT

    broken image

    info@mingcapital.cn

    broken image

    Suite 1610, 6009 Yitian Road
    Shenzhen, China

    broken image

    +86 (755) 2399 8758

    Cookie Use
    We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
    Learn More